Sarcoidosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Key Players – Pfizer, United Therapeutics, Xentria, aTyr Pharma, Kyorin Pharmaceutical, Novartis, Kinevant Sciences



DelveInsight’s analysts estimate that the sarcoidosis market is expected to show positive growth, mainly attributed to increased prevalence and the expected launch of novel therapies during the forecast period (2023–2032) LAS VEGAS, Nov. 2, 2023 /PRNewswire/ — DelveInsight’s Sarcoidosis…

Leave a Reply